|
World Nano-Economic Congress
Ireland: Day One Agenda
Morning Keynote & Plenary Presentations Day
1 Wednesday, April 20th, 2005 Keynote/Plenary Session
9:00-9:30
OPENING ADDRESS AND WELCOME:
Examining the academic and industrial infrastructure of Ireland
and how it supports the commercial development of nanotechnology
within industry.
SPEAKER: Feargal Ó Móráin, (Chairman) Executive Director Science
& Innovation, Enterprise Ireland
9:30-10:00
KEYNOTE ADDRESS:
The Commercialization of Nanotechnology and Enhancing Shareholder
Value--A Capital Markets Perspective
SPEAKER: Peter Conley, Managing Partner, Analytiq Group.
10:30-11:00 Coffee and Networking Break.
11:00-11:45
EXECUTIVE PANEL
The Future of Nanotechnology in Industry and the Trend of Nanotechnology
in Europe.
MODERATOR:: Dr. Andrew Dunn, Senior Analyst, Cientifica
PANELISTS:
Dr. Uwe Albrecht , Head of Corporate Fund, Siemens Venture Capital
GmbH (SVC)
Dr. Erich Ruetsche, Manager, Business Development & Relations,
IBM Zurich Research
Dr. Stephan Altmann, Polymer Physics, BASF AG
Dr. Susanne Arney, Director, Microsystems and Nanotechnology
Research, Bell Labs Lucent Technologies
Dr. John Magan, Assistant Director, European Commission - Information
Society & Media Directorate General – INFSO (Belgium)
11:45-12:15
EXECUTIVE PANEL
Nanotech Safety & Toxicology
MODERATOR: Dr. Andrew Dunn, Senior Analyst, Cientifica Ltd.
PANELISTS :
Dr. Rodger Duffin, Particle Toxicologist, Centre for Inflammation
Research, University of Edinburgh
Dr. Bart Gremmen, Professor, Wageningen Agricultural University
TRACK A: ELECTRONICS
1:30-2:05
Examining the various nanotechnology solutions being applied
to displays and there state of development
SPEAKER: Dave Corr, Chief Technology Officer, NTera
2:05-2:40
Analyzing the technical and economic pressures pushing the adoption
of nanotechnology solutions for data storage and how nanotechnology
options compare with competitive technologies
SPEAKER: Dr. Sining Mao, R/D Director of Advanced Devices Development,
Seagate
2:40-3:10 NETWORKING BREAK
3:10-3:45
Transitioning from Microelectronics to Nanostructural Electronics:
Novel Approaches for Process Control
SPEAKER: Dr. Anantha Sethuraman, Vice President of Product
Marketing, FEI Company.
3:45-4:20
Silicon Nanoeletronics--Innovation Challenges Ahead
SPEAKER: Dr. Jenny Patterson, Nanotechnology Program Manager,
Intel Ireland Ltd.
4:20-5:00
PANEL FORUM
Transforming the ICT Sector: How will the applications of nanotechnology
within the electronics industry transform its products.
MODERATOR: Dr. Jens Greiser, Strategic Marketing Manager, FEI
Company
PANEL:
Dave Corr, Chief Technology Officer, NTera.
Dr. Anantha Sethuraman, Vice President of Product Marketing,
FEI Company
Dr. Jenny Patterson, Nanotechnology Program Manager,
Intel Ireland Ltd.
Dr. Sining Mao, R/D Director of Advanced Devices Development,
Seagate
Handol Kim, Vice President of Business Development, D-Wave Systems
Inc.
TRACK B: PHARMACEUTICAL & MEDICAL
CHAIRPERSON:
1:30-2:05
Analyzing nanotechnology solutions for application drug and
vaccine delivery from technical, market, and regulatory perspectives
SPEAKER: Gary Liversidge, Senior Director, Project Planning
and Management, Elan.
2:05-2:40
Determining the use of nanoparticles in antibacterial applications
from personal products, textiles for medical clothing, and coatings
for sterile environments
SPEAKER: Robert Kwan, CEO, JR Nanotech
2:40-3:10 NETWORKING BREAK
3:10-3:45
How nanotechnology solutions are changing medical diagnostics
and analysis and their impact on early detection for healthcare
SPEAKER: Kevin Matthews, CEO, Oxonica.
3:45-4:20
Employing nanotechnology solutions for medical device and biomaterial
applications
SPEAKER: Michael Weiner, President and CEO, Biophan.
4:20-5:00
PANEL FORUM
Determining how will the applications of nanotechnology within
the medical & pharmaceutical industry will transform healthcare
in the future: How will nanotechnology improve medical care
and quality of life?
MODERATOR:
PANEL:
Gary Liversidge, Senior Director, Project Planning and Management,
Elan
Kevin Matthews, CEO, Oxonica
Michael Weiner, President and CEO, Biophan.
Robert Kwan, CEO, JR Nanotech.
TRACK C: NANOTECHNOLOGY & SMES
1:30-2:05
Case Study:
Integrating Nanotechnology into an SME Business
SPEAKER: Dr. Joerg Wiesmann, Managing Director, Incoatec GmbH.
2:05-2:40
Partnering & Collaboration:
Identifying when and with whom partnering makes sense.
SPEAKER: Dr. Jake Reder, Manager of New Business Development,
Cabot Corporation
2:40-3:10 NETWORKING BREAK
3:10-3:45
Funding:
Examining various funding alternatives for funding nanotechnology
initiatives from government to private equity.
SPEAKER: Dr. Martin Lyes, Head of Programmes & Directorate,
Enterprise Ireland
3:45-4:20
Infrastructure:
Identifying and establishing supplier/buyer relationships.
SPEAKER: Justin Hall-Tipping, Founding Partner, NanoHoldings
LLC
4:20-5:00
PANEL FORUM
Determining the ROI and impact of integrating nanotechnology
into your SME over the next five years: Can adopting nanotechnology
into your business be beneficial in the short-term as well as
the long-term ?
PANEL:
Dr. Joerg Wiesmann, Managing Director, Incoatec GmbH
Dr. Jake Reder, Manager of New Business Development, Cabot Corporation.
Dr. Martin Lyes, Head of Programmes & Directorate, Enterprise
Ireland.
Justin Hall-Tipping, Founding Partner, NanoHoldings LLC.
|
